T1	Devices 213 219	Marker
T2	Procedures 235 241	Ca19-9
T3	Physiology 235 241	Ca19-9
T4	Physiology 246 252	Ca72-4
T5	Disorders 360 373	Karzinogenese
T6	Chemicals_Drugs 375 385	Pepsinogen
T7	Devices 413 419	Marker
T8	Devices 521 527	Marker
T9	Procedures 610 631	Fall-Kontroll-Studien
T10	Devices 675 681	Marker
T11	Procedures 708 716	Prognose
T12	Chemicals_Drugs 1000 1011	Tumormarker
T13	Devices 1104 1110	Marker
T14	Disorders 1389 1402	Magenkarzinom
T15	Living_Beings 1403 1412	Patienten
T16	Physiology 1468 1472	VEGF
T17	Chemicals_Drugs 1468 1472	VEGF
T18	Living_Beings 1483 1490	Asiaten
T19	Procedures 1639 1655	Immunhistochemie
T20	Physiology 1697 1708	Assoziation
T21	Chemicals_Drugs 1806 1817	Tumormarker
T22	Disorders 1974 1995	Lymphknotenmetastasen
